TABLE. Demographic characteristics and viral load suppression rates of persons with human immunodeficiency virus (HIV) infection who were currently receiving and who newly initiated antiretroviral therapy (ART),* at baseline (January 2018) and 18 months after initiation of the Lusaka Province HIV Treatment Surge (June 2019) — Lusaka Province, Zambia.
| Characteristic | No. (%)† |
||
|---|---|---|---|
| Receiving ART, January 2018§ | Newly initiated on ART, January 2018–June 2019 | Receiving ART, June 2019¶ | |
|
Sex (age group, yrs)¶
| |||
|
Total, all ages
|
204,091 (100)
|
103,236 (100)
|
248,002 (100)
|
|
Male and female (<15)
|
10,193 (5) |
5,545 (5) |
10,841 (4) |
|
Total female (≥15)
|
125,000 (61)
|
60,355 (58)
|
149,792 (60)
|
| Female (15–24) |
11,342 (6) |
16,192 (16) |
14,544 (6) |
| Women (25–49) |
96,736 (47) |
40,935 (40) |
114,469 (46) |
| Women (≥50) |
16,922 (8) |
3,228 (3) |
20,779 (8) |
|
Total male (≥15)
|
68,898 (34)
|
37,336 (36)
|
87,369 (35)
|
| Male (15–24) |
4,071 (2) |
4,235 (4) |
5,722 (2) |
| Men (25–49) |
51,129 (25) |
29,976 (29) |
64,458 (26) |
| Men (≥50) |
13,698 (7) |
3,125 (3) |
17,189 (7) |
|
Viral load eligible**
|
192,950 (95) |
— |
224,764 (91) |
| Results documented |
72,142 (37) |
— |
146,532 (65) |
| Suppressed (<1,000 copies/mL) | 66,109 (92) | — | 134,046 (91) |
* At any of 201 Lusaka Province ART facilities.
† Column values might not sum to 100% because of rounding.
§ Receipt of medical or pharmacy services within the previous 90 days.
¶ Receipt of medical or pharmacy services within the previous 30 days.
** Receiving ART for at least 6 months.